BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
bliss gvs pharma ltd stock

BLISS GVS PHARMA LTD Share Price

151.8 -3.50 (-2.25%)
Dec 11 2024 03:30 PM Pharmaceuticals NSE: BLISSGVS

BLISS GVS PHARMA LTD Share Price Update

As of the latest trading session, BLISS GVS PHARMA LTD share price is currently at 151.8, which is down by -3.50 from its previous closing. Today, the stock has fluctuated between 151.15 and 156.98. Over the past year, BLISS GVS PHARMA LTD has achieved a return of 17.83 %. In the last month alone, the return has been 28.21 %. Read More...

BLISS GVS PHARMA LTD Performance

Day Range

Low151.15 High156.98
151.80

52 Week Range

Low 92.15 High 172.42
151.80

BLISS GVS PHARMA LTD Share Price

19265

506197

BLISSGVS

img img img img
No Data Available

Open Price

155.90

Prev. Close

155.31

Volume (Shares)

308557.00

Total traded value

468.38

Upper Circuit

186.37

Lower Circuit

124.24

Note: The current prices & values are delayed, Login to your account for live updates.

BLISS GVS PHARMA LTD Fundamentals


(Standalone)

Market Cap (Cr) 1589.20
PE Ratio (TTM) 35.83
Book Value / Share 97.26
Beta 0.92
ROE 7.91%
EPS (TTM) 7.67
Dividend Yield 0.32%
Net Profit Qtr (Cr) 17.04

BLISS GVS PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 182.65
Operating Expense 167.10
Net Profit 17.04
Net Profit Margin (%) 9.32
Earnings Per Share (EPS) 1.63
EBITDA 33.73
Effective Tax Rate (%) 28.67
Particulars JUN 2024 (Values in Cr)
Revenue 148.96
Operating Expense 129.64
Net Profit 19.42
Net Profit Margin (%) 13.03
Earnings Per Share (EPS) 1.85
EBITDA 33.58
Effective Tax Rate (%) 25.73
Particulars MAR 2024 (Values in Cr)
Revenue 163.82
Operating Expense 146.43
Net Profit -11.46
Net Profit Margin (%) -6.99
Earnings Per Share (EPS) -1.11
EBITDA -7.47
Effective Tax Rate (%) 24.75
Particulars DEC 2023 (Values in Cr)
Revenue 161.33
Operating Expense 140.70
Net Profit 20.72
Net Profit Margin (%) 12.84
Earnings Per Share (EPS) 1.99
EBITDA 36.56
Effective Tax Rate (%) 27.34
Particulars SEP 2023 (Values in Cr)
Revenue 171.32
Operating Expense 135.87
Net Profit 33.89
Net Profit Margin (%) 19.78
Earnings Per Share (EPS) 3.25
EBITDA 52.93
Effective Tax Rate (%) 26.43
Particulars MAR 2024 (Values in Cr)
Revenue 605.46
Operating Expense 527.61
Net Profit 50.64
Net Profit Margin (%) 8.36
Earnings Per Share (EPS) 4.85
EBITDA 99.59
Effective Tax Rate (%) 27.91
Particulars MAR 2023 (Values in Cr)
Revenue 598.34
Operating Expense 533.42
Net Profit 85.48
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 8.23
EBITDA 140.92
Effective Tax Rate (%) 26.11
Particulars MAR 2022 (Values in Cr)
Revenue 636.36
Operating Expense 545.33
Net Profit 92.66
Net Profit Margin (%) 14.56
Earnings Per Share (EPS) 8.97
EBITDA 144.57
Effective Tax Rate (%) 26.69
Particulars MAR 2021 (Values in Cr)
Revenue 465.51
Operating Expense 392.01
Net Profit 67.50
Net Profit Margin (%) 14.50
Earnings Per Share (EPS) 6.54
EBITDA 109.14
Effective Tax Rate (%) 25.97
Particulars MAR 2020 (Values in Cr)
Revenue 441.95
Operating Expense 357.24
Net Profit 92.33
Net Profit Margin (%) 20.89
Earnings Per Share (EPS) 8.95
EBITDA 137.16
Effective Tax Rate (%) 24.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 92.38
ROE % 11.02
ROCE % 14.84
Total Debt to Total Equity 0.11
EBITDA Margin 23.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 84.87
ROE % 9.01
ROCE % 12.14
Total Debt to Total Equity 0.12
EBITDA Margin 17.98
Particulars MAR 2022 (Values in Cr)
Book Value / Share 78.97
ROE % 5.35
ROCE % 14.23
Total Debt to Total Equity 0.14
EBITDA Margin 20.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.36
ROE % 9.58
ROCE % 12.20
Total Debt to Total Equity 0.16
EBITDA Margin 21.98
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.32
ROE % 13.79
ROCE % 16.92
Total Debt to Total Equity 0.17
EBITDA Margin 21.63
Particulars MAR 2024 (Values in Cr)
Book Value / Share 94.41
ROE % 7.91
ROCE % 11.19
Total Debt to Total Equity 0.08
EBITDA Margin 23.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 89.96
ROE % 9.56
ROCE % 12.81
Total Debt to Total Equity 0.10
EBITDA Margin 23.55
Particulars MAR 2022 (Values in Cr)
Book Value / Share 82.12
ROE % 11.53
ROCE % 14.59
Total Debt to Total Equity 0.11
EBITDA Margin 22.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.26
ROE % 9.38
ROCE % 11.71
Total Debt to Total Equity 0.13
EBITDA Margin 23.45
Particulars MAR 2020 (Values in Cr)
Book Value / Share 66.21
ROE % 14.36
ROCE % 17.64
Total Debt to Total Equity 0.13
EBITDA Margin 31.04
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 215.61
Total Assets 1213.86
Total Liabilities 1213.86
Total Equity 1002.98
Share Outstanding 104690822
Price to Book Ratio 1.19
Return on Assets (%) 6.21
Return on Capital (%) 6.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 102.98
Total Assets 1156.85
Total Liabilities 1156.85
Total Equity 917.42
Share Outstanding 104152672
Price to Book Ratio 0.79
Return on Assets (%) 6.12
Return on Capital (%) 6.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 177.52
Total Assets 1108.74
Total Liabilities 1108.74
Total Equity 846.46
Share Outstanding 103677922
Price to Book Ratio 0.94
Return on Assets (%) 1.35
Return on Capital (%) 1.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 144.55
Total Assets 1076.78
Total Liabilities 1076.78
Total Equity 827.90
Share Outstanding 103146672
Price to Book Ratio 1.35
Return on Assets (%) 6.36
Return on Capital (%) 7.23
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 103.31
Total Assets 1027.22
Total Liabilities 1027.22
Total Equity 750.37
Share Outstanding 103146672
Price to Book Ratio 1.52
Return on Assets (%) 9.46
Return on Capital (%) 11.39
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 169.31
Total Assets 1152.55
Total Liabilities 1152.55
Total Equity 988.44
Share Outstanding 104690822
Price to Book Ratio 1.19
Return on Assets (%) 4.39
Return on Capital (%) 4.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 84.60
Total Assets 1139.69
Total Liabilities 1139.69
Total Equity 936.99
Share Outstanding 104152672
Price to Book Ratio 0.79
Return on Assets (%) 7.50
Return on Capital (%) 8.43
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 149.48
Total Assets 1079.96
Total Liabilities 1079.96
Total Equity 851.43
Share Outstanding 103677922
Price to Book Ratio 0.94
Return on Assets (%) 8.58
Return on Capital (%) 9.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 119.51
Total Assets 945.62
Total Liabilities 945.62
Total Equity 755.64
Share Outstanding 103146672
Price to Book Ratio 1.35
Return on Assets (%) 7.13
Return on Capital (%) 7.99
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 86.62
Total Assets 855.09
Total Liabilities 855.09
Total Equity 682.94
Share Outstanding 103146672
Price to Book Ratio 1.52
Return on Assets (%) 10.79
Return on Capital (%) 12.24
Particulars MAR 2024 (Values in Cr)
Net Income 146.06
Cash from Operations 187.29
Cash from Investing -132.82
Cash from Financing -20.89
Net change in Cash -1.26
Free Cash Flow 215.62
Particulars MAR 2023 (Values in Cr)
Net Income 106.07
Cash from Operations 78.86
Cash from Investing -7.75
Cash from Financing -24.93
Net change in Cash 1.62
Free Cash Flow 172.66
Particulars MAR 2022 (Values in Cr)
Net Income 127.75
Cash from Operations 169.42
Cash from Investing -92.97
Cash from Financing -23.73
Net change in Cash 18.77
Free Cash Flow 243.42
Particulars MAR 2021 (Values in Cr)
Net Income 104.12
Cash from Operations 92.53
Cash from Investing -46.99
Cash from Financing -20.79
Net change in Cash -3.81
Free Cash Flow 101.65
Particulars MAR 2020 (Values in Cr)
Net Income 128.96
Cash from Operations 85.49
Cash from Investing -47.89
Cash from Financing -6.30
Net change in Cash -7.49
Free Cash Flow 144.75
Particulars MAR 2024 (Values in Cr)
Net Income 111.34
Cash from Operations 155.26
Cash from Investing -109.59
Cash from Financing -20.75
Net change in Cash -4.42
Free Cash Flow 193.94
Particulars MAR 2023 (Values in Cr)
Net Income 115.69
Cash from Operations 81.52
Cash from Investing -12.97
Cash from Financing -26.04
Net change in Cash 4.78
Free Cash Flow 175.81
Particulars MAR 2022 (Values in Cr)
Net Income 123.65
Cash from Operations 144.51
Cash from Investing -92.28
Cash from Financing -12.62
Net change in Cash 9.14
Free Cash Flow 218.18
Particulars MAR 2021 (Values in Cr)
Net Income 91.18
Cash from Operations 89.68
Cash from Investing -61.62
Cash from Financing -11.67
Net change in Cash -6.32
Free Cash Flow 97.74
Particulars MAR 2020 (Values in Cr)
Net Income 121.71
Cash from Operations 89.88
Cash from Investing -57.88
Cash from Financing -2.86
Net change in Cash -2.72
Free Cash Flow 150.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2328.95 49.21 23.58 39453.82 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 157.80
  • 26 Days 143.10
  • 10 Days 155.10
  • 50 Days 138.00
  • 12 Days 153.50
  • 100 Days 130.00
  • 20 Days 146.40
  • 200 Days 130.20
154.45
PIVOT
First Resistance 158.81
Second Resistance 162.30
Third Resistance 166.66
First Support 150.96
Second Support 146.60
Third Support 143.11
RSI 63.06
MACD 10.41
Commodity Channel Index (CCI) 51.58
ADX 48.90
Williams % R -32.50

Over 1 Month

down

28.21

Over 3 Months

down

19.24

Over 6 Months

down

45.65

Over 1 Year

down

17.83

Over 3 Years

down

14.65

Over 5 Years

down

0.02

BLISS GVS PHARMA LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BLISS GVS PHARMA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
46.48
Promoter Holdings
34.81
FII
12.13
DII
6.56
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Narsimha Shibroor Kamath Shareholding of Promoter and Promoter Group 3.1957024E7 30.39
Arian Investment Limited Public Shareholding 9240603.0 8.79
Life Insurance Corporation Of India Public Shareholding 6901355.0 6.56
Gulbarga Trading And Investment Private Public Shareholding 5837000.0 5.55
Arjun Gautam Ashra . Public Shareholding 5049000.0 4.8
Gautam Rasiklal Ashra Public Shareholding 2951571.0 2.81
Vibha Gagan Sharma Shareholding of Promoter and Promoter Group 2475000.0 2.35
Shruti Vishal Rao Shareholding of Promoter and Promoter Group 2110000.0 2.01
Coeus Global Opportunities Fund Public Shareholding 1859594.0 1.77
Ramadas Vasudev Kamath. Shareholding of Promoter and Promoter Group 28988.0 0.03
Punita Sharma Shareholding of Promoter and Promoter Group 24962.0 0.02
Shibroor Gokuldas Kamath Shareholding of Promoter and Promoter Group 8000.0 0.01
Gagan Harsh Sharma Shareholding of Promoter and Promoter Group 0.0 0.0
Ramadas Vasudev Kamath. Shareholding of Promoter and Promoter Group 3200.0 0.0

BLISS GVS PHARMA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-12 0.5 Final 2023-07-13 Equity shares 2022-06-20 0.5 Final 2022-06-21 Equity shares 2021-09-13 0.5 Final 2021-09-14 Equity shares 2020-09-17 0.5 Final 2020-09-19 Equity shares 2019-09-12 1.0 Final 2019-09-14 Equity shares 2018-08-14 1.0 Final 2018-08-18 Equity shares 2017-09-18 0.6 Final 2017-09-20 Equity shares 2016-09-06 0.5 Final 2016-09-08 Equity shares 2015-09-08 0.5 Final 2015-09-10 Equity shares 2015-02-24 0.2 Interim 2015-02-25 Equity shares 2014-08-13 0.5 Final 2014-08-18 Equity shares 2013-08-01 0.4 Final 2013-08-05 Equity shares 2013-02-25 0.3 Interim 2013-02-26 Equity shares 2012-08-02 0.4 Final 2012-08-06 Equity shares 2011-11-24 0.35 Interim 2011-11-25 Equity shares 2011-07-14 0.3 Final 2011-07-18 Equity shares 2010-11-25 0.3 Interim 2010-11-27 Equity shares 2010-07-22 0.5 Final 2010-07-26 Equity shares 2009-08-13 0.15 Final 2009-08-17 Equity shares 2008-05-14 0.1 Interim 2008-05-15 Equity shares 2007-09-13 1.0 Final 2007-09-17 Equity shares
Ex-Date Ex-Bonus Ratio
2008-09-30 2008-09-26 3:5 2005-10-01 2005-09-28 2:5
Ex-Date Old FV NEW FV Record Date
2008-03-11 10.0 1.0 2008-03-18

Learn More About Stocks

About BLISS GVS PHARMA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BLISS GVS PHARMA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Bliss GVS Pharma Ltd?

Answer Field

The share price of Bliss GVS Pharma Ltd for NSE is ₹ 151.8 and for BSE is ₹ 152.2.

What is the Market Cap of Bliss GVS Pharma Ltd?

Answer Field

The market cap of Bliss GVS Pharma Ltd for NSE is ₹ 15,89.20 Cr. and for BSE is ₹ 15,93.39 Cr. as of now.

What is the 52 Week High and Low of Bliss GVS Pharma Ltd?

Answer Field

The 52 Week High and Low of Bliss GVS Pharma Ltd for NSE is ₹ 172.42 and ₹ 92.15 and for BSE is ₹ 172.40 and ₹ 92.25.

How to Buy Bliss GVS Pharma Ltd share?

Answer Field

You can trade in Bliss GVS Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bliss GVS Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 17.83%.

What is the Current Share Price of Bliss GVS Pharma Ltd?

Answer Field

Bliss GVS Pharma Ltd share price is for NSE ₹ 151.8 & for BSE ₹ 152.2 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Bliss GVS Pharma Ltd Share?

Answer Field

The market cap of Bliss GVS Pharma Ltd for NSE ₹ 15,89.20 & for BSE ₹ 15,93.39 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Bliss GVS Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Bliss GVS Pharma Ltd share is 35.83.

What is the PB ratio of Bliss GVS Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Bliss GVS Pharma Ltd share is 97.26.

How to Buy Bliss GVS Pharma Ltd Share?

Answer Field

You can trade in Bliss GVS Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bliss GVS Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Bliss GVS Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bliss GVS Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader